American Express (AXP) to cut 5% of jobs
Newsquawk Staff ·
American Express (AXP) to cut 5% of jobs.
What it means
Headcount reductions of this size at a large card issuer sit in the cost-management category rather than the distress category; in past episodes at payments and consumer-finance names, single-digit percentage cuts have been read as margin protection against slowing revenue growth or rising credit costs rather than as a credit event in themselves. The distinction worth drawing is whether the cuts land in corporate and overhead functions, which markets have historically treated as operating-leverage discipline, or in customer-facing and risk functions, which would carry a different signal about volumes. For a card issuer, the relevant transmission runs through the spending and charge-off data the company already reports monthly, since that disclosure cadence means any underlying deterioration shows up in the trust data before it shows up in the quarter. Prior form at this name has been to frame restructuring around efficiency rather than retrenchment, and the language of the accompanying statement will matter for how the street maps it onto full-year guidance. The immediate follow-ons are any severance charge and updated expense trajectory in the next quarterly print, plus whether peers in the consumer-credit peer set announce parallel moves, which in the past has been the tell for a cyclical turn rather than an idiosyncratic decision.
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)
- Booz Allen (BAH) Q2 2026 (USD): Adj. EPS 1.76 (exp. 1.48), Revenue 2.80bln (prev. 2.81bln)
Related headlines
- SLB (SLB) Q3 2026 (USD): adj. EPS 0.64 (exp. 0.62), Revenue 9.45bln (exp. 9.27bln)2 hours ago
- Citi (C) has been granted approval by China for its securities unit4 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand12 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT14 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated15 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network15 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud15 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE16 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash16 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)16 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)16 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)16 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone18 hours ago
- DataDog (DDOG) recently offered almost USD 4bln to acquire Upwind Security, but the Co. hasn't accepted the offer, reports The Information citing sources19 hours ago
- Statnews posts on X, "Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the Chinese biotech sector"19 hours ago